Creatine and Creatinine Metabolism - Physiological Reviews

July 2000 CREATINE AND CREATININE METABOLISM 1197
sponse to estrogen withdrawal and tamoxifen therapy of human
breast cancer xenografts evaluated by in vivo 31 P magnetic resonance
spectroscopy, creatine kinase activity, and apoptotic index.
Cancer Res 55: 4146–4150, 1995.
514. KRISTIANSEN E. The role of aberrant crypt foci induced by the
two heterocyclic amines 2-amino-3-methyl-imidazo[4,5-f]quinoline
(IQ) and 2-amino-1-methyl-6-phenyl-imidazo[4,5-b]pyridine (PhIP)
in the development of colon cancer in mice. Cancer Lett 110:
187–192, 1996.
515. KU C-P AND PASSOW H. Creatine and creatinine transport in old
and young human red blood cells. Biochim Biophys Acta 600:
212–227, 1980.
516. KUPRIYANOV VV, BALABAN RS, STEINSCHNEIDER AY, LA-
KOMKIN VL, RUUGE EK, SMIRNOV VN, AND SAKS VA. 31 P-NMR
study of the creatine kinase reaction mechanism in vitro and in
vivo. In: Myocardial Metabolism, Proc. 6th Joint USA-USSR Symposium,
Baku, USSR, 1984, edited by V. N. Smirnov and A. M.
Katz. Chichester, UK: Horwood, 1987, p. 297–325.
517. KUPRIYANOV VV, LAKOMKIN VL, STEINSCHNEIDER AY, NO-
VIKOVA NA, SEVERINA MY, KAPELKO VI, AND SAKS VA. The role
of phosphocreatine and ATP in contraction of normal and ischemic
heart. Biomed Biochim Acta 46 Suppl: S493–S498, 1987.
518. KUPRIYANOV VV, STEINSCHNEIDER AY, RUUGE EK,
KAPEL’KO VI, ZUEVA MY, LAKOMKIN VL, SMIRNOV VN, AND
SAKS VA. Regulation of energy flux through the creatine kinase
reaction in vitro and in perfused rat heart. 31 P-NMR studies.
Biochim Biophys Acta 805: 319–331, 1984.
519. KURAHASHI M AND KUROSHIMA A. Mechanism of triiodothyronine-induced
creatinuria in the rat. Am J Physiol Endocrinol
Metab Gastrointest Physiol 233: E91–E96, 1977.
520. KURODA M. Study on impaired metabolism of guanidinoacetic
acid in chronic renal failure rabbits with special reference to
impaired conversion of arginine to guanidinoacetic acid. Nephron
65: 605–611, 1993.
521. KUROSAKA R, WAKABAYASHI K, USHIYAMA H, NUKAYA H,
ARAKAWA N, SUGIMURA T, AND NAGAO M. Detection of 2-amino-
1-methyl-6-(4-hydroxyphenyl)imidazo[4,5-b]pyridine in broiled
beef. Jpn J Cancer Res 83: 919–922, 1992.
522. KUROSAWA Y, IWANE H, HAMAOKA T, SHIMOMITSU T, KAT-
SUMURA T, SAKO T, KUWAMORI M, AND KIMURA N. Effects of
oral creatine supplementation on high- and low-intensity grip
exercise performance (Abstract). Med Sci Sports Exercise 29:
S251, 1997.
523. KUSHIDA H, WAKABAYASHI K, SATO H, KATAMI M, KURO-
SAKA R, AND NAGAO M. Dose-response study of MeIQx carcinogenicity
in F344 male rats. Cancer Lett 83: 31–35, 1994.
524. KUSHMERICK MJ. Energy balance in muscle activity: simulations
of ATPase coupled to oxidative phosphorylation and to creatine
kinase. Comp Biochem Physiol B Biochem 120: 109–123, 1998.
525. KUSHMERICK MJ, MOERLAND TS, AND WISEMAN RW. Mammalian
skeletal muscle fibers distinguished by contents of phosphocreatine,
ATP, and P i. Proc Natl Acad Sci USA 89: 7521–7525, 1992.
526. KUZHIKANDATHIL EV AND MOLLOY GR. Prostaglandin E 1,E 2,
and cholera toxin increase transcription of the brain creatine
kinase gene in human U87 glioblastoma cells. Glia 15: 471–479,
1995.
527. LABELLA JJ, DAOOD MJ, KORETSKY AP, ROMAN BB, SIECK
GC, WIERINGA B, AND WATCHKO JF. Absence of myofibrillar
creatine kinase and diaphragm isometric function during repetitive
activation. J Appl Physiol 84: 1166–1173, 1998.
528. LAI MM AND BOOTH FW. Cytochrome c mRNA and �-actin mRNA
in muscles of rats fed �-GPA. J Appl Physiol 69: 843–848, 1990.
529. LANG H. (Editor). Creatine Kinase Isoenzymes: Pathophysiology
and Clinical Application. Berlin: Springer-Verlag, 1981.
530. LANG H, POLSTER M, AND BRANDSCH R. Rat liver dimethylglycine
dehydrogenase. Flavinylation of the enzyme in hepatocytes in
primary culture and characterization of a cDNA clone. Eur J Biochem
198: 793–799, 1991.
531. LANGE R, INGWALL J, HALE SL, ALKER KJ, BRAUNWALD E,
AND KLONER RA. Preservation of high-energy phosphates by verapamil
in reperfused myocardium. Circulation 70: 734–741,
1984.
532. LASER A, INGWALL JS, TIAN R, REIS I, HU K, GAUDRON P,
ERTL G, AND NEUBAUER S. Regional biochemical remodeling in
non-infarcted tissue of rat heart post-myocardial infarction. J Mol
Cell Cardiol 28: 1531–1538, 1996.
533. LASER A, NEUBAUER S, TIAN R, HU K, GAUDRON P, INGWALL
JS, AND ERTL G. Long-term beta-blocker treatment prevents
chronic creatine kinase and lactate dehydrogenase system
changes in rat hearts after myocardial infarction. J Am Coll Cardiol
27: 487–493, 1996.
534. LASER REUTERSWÄRD A, SKOG K AND JÄGERSTAD M. Mutagenicity
of pan-fried bovine tissues in relation to their content of
creatine, creatinine, monosaccharides and free amino acids. Food
Chem Toxicol 25: 755–762, 1987.
535. LASKOWSKI MB, CHEVLI R, AND FITCH CD. Biochemical and
ultrastructural changes in skeletal muscle induced by a creatine
antagonist. Metabolism 30: 1080–1085, 1981.
536. LAVILLE M, POZET N, FOUQUE D, HADJ-AÏSSA A, FAUVEL JP,
AND ZECH P. Factors affecting urinary excretion of creatinine. In:
Guanidino Compounds in Biology and Medicine, edited by P. P.
De Deyn, B. Marescau, V. Stalon, and I. A. Qureshi. London:
Libbey, 1992, p. 261–268.
537. LAWLEY PD. N-nitroso compounds. In: Chemical Carcinogenesis
and Mutagenesis I, edited by C. S. Cooper and P. L. Grover.
Berlin: Springer, 1990, p. 409–469.
538. LAWSON JWR AND VEECH RL. Effects of pH and free Mg 2� on the
K eq of the creatine kinase reaction and other phosphate hydrolyses
and phosphate transfer reactions. J Biol Chem 254: 6528–
6537, 1979.
539. LAWSON T, KOLAR C, AND REYES T. Mutagenicity of 2-amino-1methyl-6-phenylimidazo[4,5-b]pyridine
(PhIP) when activated by
hamster pancreatic duct epithelial cells: a chemopreventive role
for glutathione. Mutat Res 375: 73–78, 1997.
540. LAYTON DW, BOGEN KT, KNIZE MG, HATCH FT, JOHNSON VM,
AND FELTON JS. Cancer risk of heterocyclic amines in cooked
foods: an analysis and implications for research. Carcinogenesis
16: 39–52, 1995.
541. LEAVER DD, SWANN PF, AND MAGEE PN. The induction of
tumours in the rat by a single oral dose of N-nitrosomethylurea.
Br J Cancer 23: 177–187, 1969.
542. LEE H, GONG C, WU S, AND IYENGAR MR. Accumulation of
phosphocreatine and creatine in the cells and fluid of mouse
seminal vesicles is regulated by testosterone. Biol Reprod 44:
540–545, 1991.
543. LEE H, KIM J-H, CHAE Y-J, OGAWA H, LEE M-H, AND GERTON
GL. Creatine synthesis and transport systems in the male rat
reproductive tract. Biol Reprod 58: 1437–1444, 1998.
544. LEE H, LIN M-Y, AND LIN ST. Characterization of the mutagen
2-amino-3-methylimidazo[4,5-f]quinoline prepared from a 2-methylpyridine/creatinine/acetylformaldehyde
model system. Mutagenesis
9: 157–162, 1994.
545. LEE H, OGAWA H, FUJIOKA M, AND GERTON GL. Guanidinoacetate
methyltransferase in the mouse: extensive expression in
Sertoli cells of testis and in microvilli of caput epididymis. Biol
Reprod 50: 152–162, 1994.
546. LEE H, WANG H-W, SU H-Y, AND HAO NJ. The structure-activity
relationships of flavonoids as inhibitors of cytochrome P-450 enzymes
in rat liver microsomes and the mutagenicity of 2-amino-
3-methyl-imidazo[4,5-f]quinoline. Mutagenesis 9: 101–106, 1994.
547. LEE HJ, FILLERS WS, AND IYENGAR MR. Phosphocreatine, an
intracellular high-energy compound, is found in the extracellular
fluid of the seminal vesicles in mice and rats. Proc Natl Acad Sci
USA 85: 7265–7269, 1988.
548. LEFER AM AND LEFER DJ. Pharmacology of the endothelium in
ischemia-reperfusion and circulatory shock. Annu Rev Pharmacol
Toxicol 33: 71–90, 1993.
549. LEFURGEY A, DAVILLA SD, KOPF DA, SOMMER JR, AND IN-
GRAM P. Real-time quantitative elemental analysis and mapping:
microchemical imaging in cell physiology. J Microsc 165: 191–223,
1992.
550. LELE PS, DUNN SR, SIMENHOFF ML, FIDDLER W, AND PENSA-
BENE JW. Evidence for generation of the precarcinogen nitrosodimethylamine
in the small intestine in chronic renal failure.
Kidney Int 24 Suppl 16: S-229–S-233, 1983.